In terms of market performance, Bone Biologics Corp had a somewhat inconsistent run in. The highest value for the stock in the past year was $10.56 on 12/28/23, while the lowest value was $0.80 on 09/13/24.
52-week price history of BBLG Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Bone Biologics Corp’s current trading price is -80.87% away from its 52-week high, while its distance from the 52-week low is 152.50%. The stock’s price range during this period has fluctuated between $0.80 and $10.56. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 2.15 million for the day, which was evidently lower than the average daily volume of 4.92 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Bone Biologics Corp (BBLG) has experienced a quarterly rise of 68.35% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.07M and boasts a workforce of 2 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.57, with a change in price of +0.43. Similarly, Bone Biologics Corp recorded 3,246,459 in trading volume during the last 100 days, posting a change of +27.04%.
BBLG Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BBLG stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
BBLG Stock Stochastic Average
Bone Biologics Corp’s raw stochastic average for the past 50 days is currently at 62.56%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 43.85%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 34.87% and 23.76%, respectively.
BBLG Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -55.31% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 25.47%. Over the past 30 days, the price of BBLG has fallen by 10.99%. And in the last five days, it has surged by 20.96%.
